Subsidiary Shandong Sito Bio-technology(300583.SZ) obtains approval notice for listing application of chemical raw material drug mirtazapine succinate.

Shandong Sito Bio-technology (300583.SZ) announced that its holding subsidiary, Shandong Sray Pharmaceutical Co., Ltd., recently received the "Notice of Approval for Market Application of Chemical Raw Materials for Indacaterol Maleate" issued by the National Medical Products Administration. Indacaterol Maleate is a long-acting 2-adrenergic receptor agonist. After inhalation, it exerts bronchodilator effects locally in the lungs and is suitable for maintenance treatment of chronic obstructive pulmonary disease (COPD) in adults. The marketed formulations include inhalation powders (single and combination) such as Indacaterol Maleate Inhalation Powder and Glycopyrronium Bromide Inhalation Powder.